Showing results (511-520 of 566) with videos related to
Sort By:
Pageof 57
Frontiers in Public Health|February 26, 2021
Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer PatientsIlaria Durosini, Rosanne Janssens, Reinhard Arnou, et al.ESMO Open|April 10, 2019
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitorsGiovanni Fucà, Giulia Galli, Marta Poggi, et al.Breast Care (Basel, Switzerland)|February 20, 2018
Neoadjuvant Chemotherapy Exerts Selection Pressure Towards Luminal Phenotype Breast CancerGiulia Galli, Giacomo Bregni, Stefano Cavalieri, et al.BMJ Open|April 7, 2022
Clinical and imaging characteristics of patients with COVID-19 predicting hospital readmission after emergency department discharge: a single-centre cohort study in ItalyMaria Giulia Galli, Olivera Djuric, Giulia Besutti, et al.Cancers|April 3, 2021
Beyond First-Line Immunotherapy: Potential Therapeutic Strategies Based on Different Pattern Progressions: Oligo and Systemic ProgressionArsela Prelaj, Chiara Carlotta Pircher, Giacomo Massa, et al.Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|July 22, 2026
[Application of artificial intelligence for surgical skill assessment and quality control in minimally invasive surgery: progress, problems and prospect]Boer Su, Ying Zhang, Zhixian Yan, et al.Cancer Treatment Reviews|June 5, 2018
Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitorsLuigia Stefania Stucci, Stella D'Oronzo, Marco Tucci, et al.ESMO Open|May 30, 2020
LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trialClaudio Vernieri, Monica Ganzinelli, Eliana Rulli, et al.Journal of Personalized Medicine|June 2, 2021
Evaluation of Drug-Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase InhibitorsMario Occhipinti, Marta Brambilla, Giulia Galli, et al.Cancers|October 16, 2024
Phase I Clinical Trial on Pleural Mesothelioma Using Neoadjuvant Local Administration of Paclitaxel-Loaded Mesenchymal Stromal Cells (PACLIMES Trial): Study Rationale and DesignGiulia Maria Stella, Daniela Lisini, Paolo Pedrazzoli, et al.Pageof 57